TY - JOUR
T1 - Targeting Cell Senescence for the Treatment of Age-Related Bone Loss
AU - Pignolo, Robert J.
AU - Samsonraj, Rebekah M.
AU - Law, Susan F.
AU - Wang, Haitao
AU - Chandra, Abhishek
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/4/15
Y1 - 2019/4/15
N2 - Purpose of Review: We review cell senescence in the context of age-related bone loss by broadly discussing aging mechanisms in bone, currently known inducers and markers of senescence, the senescence-associated secretory phenotype (SASP), and the emerging roles of senescence in bone homeostasis and pathology. Recent Findings: Cellular senescence is a state of irreversible cell cycle arrest induced by insults or stressors including telomere attrition, oxidative stress, DNA damage, oncogene activation, and other intrinsic or extrinsic triggers and there is mounting evidence for the role of senescence in aging bone. Cellular aging also instigates a SASP that exerts detrimental paracrine and likely systemic effects. Summary: With aging, multiple cell types in the bone microenvironment become senescent, with osteocytes and myeloid cells as primary contributors to the SASP. Targeting undesired senescent cells may be a favorable strategy to promote bone anabolic and anti-resorptive functions in aging bone, with the possibility of improving bone quality and function with normal aging and/or disease.
AB - Purpose of Review: We review cell senescence in the context of age-related bone loss by broadly discussing aging mechanisms in bone, currently known inducers and markers of senescence, the senescence-associated secretory phenotype (SASP), and the emerging roles of senescence in bone homeostasis and pathology. Recent Findings: Cellular senescence is a state of irreversible cell cycle arrest induced by insults or stressors including telomere attrition, oxidative stress, DNA damage, oncogene activation, and other intrinsic or extrinsic triggers and there is mounting evidence for the role of senescence in aging bone. Cellular aging also instigates a SASP that exerts detrimental paracrine and likely systemic effects. Summary: With aging, multiple cell types in the bone microenvironment become senescent, with osteocytes and myeloid cells as primary contributors to the SASP. Targeting undesired senescent cells may be a favorable strategy to promote bone anabolic and anti-resorptive functions in aging bone, with the possibility of improving bone quality and function with normal aging and/or disease.
KW - Aging
KW - Cell senescence
KW - Osteoporosis
KW - Senescence-associated secretory phenotype
KW - Senolytic drug
KW - Telomere dysfunction
UR - http://www.scopus.com/inward/record.url?scp=85062603175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062603175&partnerID=8YFLogxK
U2 - 10.1007/s11914-019-00504-2
DO - 10.1007/s11914-019-00504-2
M3 - Review article
C2 - 30806947
AN - SCOPUS:85062603175
SN - 1544-1873
VL - 17
SP - 70
EP - 85
JO - Current osteoporosis reports
JF - Current osteoporosis reports
IS - 2
ER -